Doctors Recommend Clearwayz™ Sinus, Respiratory and Immune Support as a Safe Alternative to Cold, Flu and Allergy Medicines
Los Angeles, CA (PRWEB) December 05, 2013 -- Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced a new application for their dietary supplement Clearwayz. The product which currently supports healthy sinus and immune function has also shown the ability in multiple open label trials to support healthy respiratory function and increase expired nitric oxide production.
Clearwayz was developed by a team of Doctors at Targeted Medical Pharma who specialize in the nutrient support of health. Clearwayz is the first oral supplement to combine grape seed extract, l-arginine, and choline with "Targeted Cellular Technology," a patented molecular system used to stimulate the rapid cellular uptake and utilization of nutrients. The proprietary formulation in Clearwayz provides the body with the neurotransmitter precursors needed to support natural anti-inflammatory processes in the sinuses and bronchi, as well as support a healthy immune response. Clearwayz is now available and can be purchased from a physician in your area or online at http://www.clearwayz.com.
"Each ingredient in Clearwayz has been extensively researched for both safety and efficacy, and have established health benefits for people who suffer from congestion or trouble breathing due to allergies, sinusitis, asthma, cold or flu," said William Shell, M.D., CEO and Chief Scientific Officer of Targeted Medical Pharma, Inc. "The use of polyphenols and amino acids to address inflammation and respiratory distress is well recognized in the medical community. Clearwayz combines these ingredients into a proprietary blend which leverages our Targeted Cellular Technology platform to provide sustained sinus, immune and pulmonary support."
About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that develops medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and recently launched its first dietary supplement, Clearwayz™. The products are sold directly to physicians and pharmacies in the U.S. The company also is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.
Marcus Charuvastra, Targeted Medical Pharma, Inc., http://www.tmedpharma.com, +1 310-474-9809 Ext: 177, [email protected]
Share this article